Showing results (121-130 of 329) with videos related to

Sort By:
Pageof 33
The International Journal of Neuropsychopharmacology|February 15, 2014
Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biologyHendrik Wesseling, Paul C Guest, Santiago G Lago, et al.
The International Journal of Neuropsychopharmacology|January 23, 2015
Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolismMichael G Gottschalk, Hendrik Wesseling, Paul C Guest, et al.
Expert Review of Molecular Diagnostics|September 10, 2011
Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disordersWolfgang Kluge, Murtada Alsaif, Paul C Guest, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2021
Testing the Anti-inflammatory Effects of Curcuminoids in Patients with Colorectal CancerTannaz Jamialahmadi, Paul C Guest, Aida Tasbandi, et al.
Biomarkers in Medicine|December 12, 2013
The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patientsPaul C Guest, Man K Chan, Michael G Gottschalk, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2016
The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia PatientsJohann Steiner, Paul C Guest, Hassan Rahmoune, et al.
Expert Review of Proteomics|February 2, 2012
Proteomic approaches to unravel the complexity of schizophreniaDaniel Martins-de-Souza, Paul C Guest, Hassan Rahmoune, et al.
International Review of Neurobiology|November 5, 2011
Challenges of introducing new biomarker products for neuropsychiatric disorders into the marketSabine Bahn, Richard Noll, Anthony Barnes, et al.
Advances in Experimental Medicine and Biology|July 31, 2021
Effects of Curcumin and Its Analogues on Infectious DiseasesReza Ranjbar, Hossein Bagheri, Faezeh Ghasemi, et al.
Pageof 33